期刊文献+

三阴性乳腺癌患者中S1PR1、Caspase-3的表达及其与病理特征的关系分析 被引量:2

Analysis on the Expressions of SiPR1 and Caspase-3 in Patients with Triple Negative Breast Cancer and Their Relationships with Pathological Features
下载PDF
导出
摘要 目的探讨三阴性乳腺癌(TNBC)患者中S1PR1、Caspase-3的表达及其与病理特征的关系。方法回顾性分析76例乳腺癌患者的病历资料,其中TNBC患者20例(TNBC组),非TNBC患者56例(非TNBC组)。采用免疫组化法检测两组乳腺癌标本中的S1PR1、Caspase-3表达,分析二者阳性表达与TNBC病理特征的关系。结果TNBC组标本中S1PR1、Caspase-3的阳性表达率高于非TNBC组(P<0.05)。不同淋巴结转移情况、TNM分期的TNBC患者的S1PR1、Caspase-3表达存在显著差异(P<0.05)。结论S1PR1、Caspase-3在TNBC患者中表达升高,且二者的表达与淋巴结转移情况、TNM分期具有密切联系。 Objective To explore the expressions of S1PR1 and Caspase-3 in patients with triple negative breast cancer(TNBC)and their relationships with pathological features.Methods The medical records of 76 patients with breast cancer were retrospectively analyzed,including 20 TNBC patients(TNBC group)and 56 non-TNBC patients(non-TNBC group).The expressions of S1PR1 and Caspase-3 in breast cancer specimens of the two groups were detected by immunohistochemistry,and the relationships between the positive expressions of the two indicators and the pathological features of TNBC were analyzed.Results The positive expression rates of SIPR1 and Caspase-3 in TNBC group were higher than those in non-TNBC group(P<0.05).There were significant differences in the expressions of SIPR1 and Caspase-3 in TNBC patients with different lymph node metastasis and TNM stage(P<0.05).Conclusions The expressions of S1PR1 and Caspase-3 increase in TNBC patients,and their expressions are closely related to lymph node metastasis and TNM stage.
作者 范学亮 王中山 王春锋 FAN Xueliang;WANG Zhongshan;WANG Chunfeng(Department of Pathology,Zhengzhou KingMed Clinical Laboratory Center,Zhengzhou 450016,China)
出处 《临床医学工程》 2023年第6期867-868,共2页 Clinical Medicine & Engineering
关键词 三阴性乳腺癌 S1PR1 CASPASE-3 病理特征 Triple negative breast cancer S1PRl Caspase-3 Pathological feature
  • 相关文献

参考文献6

二级参考文献33

  • 1Dent R, Trudeau M, Pritchard K1, et al. Triple-negative breast cancer: clinical features and patterns of recurrence [J]. Clin Cancer Res, 2007,13 ( 15 Pt 1 ) : 4429 - 4434. 被引量:1
  • 2Lee JH,Cho YS, Lee JY,et al. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer[J]. Ann Surg ,2009,249(6) :933 - 941. 被引量:1
  • 3Xu Y, Liu LF, Qiu XS, et al. CCI.21/CCR7 promotes G2/ M phase progression via the ERK pathway in human non small cell lung cancer cells [J]. PLoS ONE, 2011, 6 (6) :e21119. 被引量:1
  • 4Li JY, Ou ZL, Yu SJ,et al. The ehemokine receptor CCR4 promotes tumor growth and lung metastasis in breast caneer[J]. Breast Cancer Res Treat, 2012, 13:(3): 837 - 848. 被引量:1
  • 5Liu YX,Ji R,Li JY,etal. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis[J]. J Ea'p Clin Cancer Res ,2010,29 : 16. 被引量:1
  • 6Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast eancer[J]. J Clin 0acol,2008, 26(8) :1275 - 1281. 被引量:1
  • 7Gelmon KA, Tischkowitz M, Mackay H, et al. Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer : a phase 2, muhicentre, open-iabei, non-randomised study[J]. Lancet Onco1,2011,12(9) 852 - 861. 被引量:1
  • 8O'Shaughnessy J, Osborne C, Pippen JE, et aL. Iniparib plus chemotherapy in metastatic triple negative breast cancer[J]. N Engl J Med, 201 ;i , 364 (3) : 2(}5 - 2 / 4. 被引量:1
  • 9Bosch A, Eroles P, Zaragoza R, et al. Triple negative breast cancer: molecular features, patbogenesis, treaiment and current lines of research[J]. Cancer Treat Rev,21)lO, 36(3) :206 - 215. 被引量:1
  • 10Ishida T,Joh T,Uike N,et al. Defucosylated anti-CCR4 monoclonal antibody (KW (1761) for relapsed adult T-cell leukemia lymphoma a multicenter phase II study E J 1. J CLin Onco1,2(112,30(8) 837 - 842. 被引量:1

共引文献19

同被引文献19

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部